News ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 05:11:41 14/03/26 am AEDT			5-day change	1st Jan Change
231.58 ^USD	-0.36%		-8.77%	-4.23%

12/03	Resmed Insider Sold Shares Worth $1,252,902, According to a Recent SEC Filing	MT
11/03	Baird Adjusts Price Target on ResMed to $272 From $281, Maintains Neutral Rating	MT

All News

12/03	Resmed Insider Sold Shares Worth $1,252,902, According to a Recent SEC Filing	MT
11/03	Baird Adjusts Price Target on ResMed to $272 From $281, Maintains Neutral Rating	MT
06/03	Resmed Insider Sold Shares Worth $520,440, According to a Recent SEC Filing	MT
05/03	Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains out of Reach	AQ
04/03	ASX Biggest Gainers	MT
03/03	Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach	GL
27/02	SomnoMed Limited Announces Management Appointments	CI
25/02	Shares of Resmed Fall 3% After Declaring Plan to Open New US Distribution Center	MT
25/02	Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana	CI
25/02	ResMed to Open New Distribution Center in Indiana	MT
25/02	ResMed expands US operations with new distribution center in Indiana	RE
25/02	Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana	GL
12/02		FA
12/02	Resmed : Introduces Full Face Fabric Mask Designed for Comfort and Improved Sleep Health in the US	PU
11/02	Resmed Insider Sold Shares Worth $1,366,436, According to a Recent SEC Filing	MT
07/02	Resmed Insider Sold Shares Worth $502,620, According to a Recent SEC Filing	MT
06/02	ResMed Chief Legal Officer Sells 50 Common Shares Of Firm	MT
06/02	ResMed Director Sells 2,000 Shares	MT
06/02	ASX Biggest Gainers	MT
05/02	ASX Biggest Gainers	MT
04/02	Resmed Insider Sold Shares Worth $257,030, According to a Recent SEC Filing	MT
03/02	Sleep device maker ResMed ramps up doctor outreach to tap Ozempic surge	RE
03/02	America's New Gold Rush (and Why It Just Face-Planted)
02/02	Morgans Financial Upgrades ResMed to Buy from Accumulate, Price Target is AU$47.73	MT
02/02	Analyst recommendations: Apple, Autodesk, Best Buy, Caterpillar, PayPal…